NCAPG2 and posterior cortical atrophy: In addition, we found that NCAPG2 expression was upregulated in PCa patients with poor response after primary treatment (CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease) (Wilcoxon test P < 0.001, Additional file 1: Figure S1h).